Alcohol consumption and associated risk factors in Burkina Faso: results of a population-based cross-sectional survey.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
10 02 2022
Historique:
entrez: 11 2 2022
pubmed: 12 2 2022
medline: 21 4 2022
Statut: epublish

Résumé

Lifestyle modifiable risk factors are a leading preventable cause of non-communicable diseases, with alcohol consumption among the most important. Studies characterising the prevalence of alcohol consumption in low-income countries are lacking. This study describes the prevalence of different levels of alcohol consumption in Burkina Faso and its associated factors. Data from the 2013 Burkina Faso WHO STEPwise Approach to Surveillance survey were analysed. The prevalence of alcohol consumption over the last 30 days was recoded into categories according to WHO recommendations: low, mid or abusive alcohol consumption. Multinomial logistic regression analyses identified factors associated with the different levels of alcohol consumption. Population-based cross-sectional survey in Burkina Faso. 4692 participants of both sexes aged 25-64 years were included in the study. In the whole sample, 3559 participants (75.8% (72.5%-78.7%)) were not consuming any alcohol, 614 (12.9% (10.9%-15.3%)) had low alcohol consumption, 399 (8.5% (7.1%-10.1%)) had mid alcohol consumption and 120 (2.7% (2.0%-3.7%)) had abusive consumption. Age was associated with alcohol intake with a gradient effect and older people having a higher level of consumption (adjusted OR (AOR): 2.36, 95% CI (1.59 to 3.51) for low consumption, 2.50 (1.54 to 4.07) for mid consumption and 2.37 (1.01 to 5.92) for abusive consumption in comparison with no consumption). Tobacco consumption was also significantly associated with alcohol intake with a gradient effect, those with higher tobacco consumption being at higher risk of abusive alcohol intake (AOR: 6.08 (2.75 to 13.4) for moderate consumption and 6.58 (1.96 to 22.11) for abusive consumption). Our data showed an important burden of alcohol consumption in Burkina Faso, which varied with age and tobacco use. To effectively reduce alcohol consumption in Burkina Faso, comprehensive control and prevention campaigns should consider these associated factors.

Identifiants

pubmed: 35144955
pii: bmjopen-2021-058005
doi: 10.1136/bmjopen-2021-058005
pmc: PMC8845319
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e058005

Informations de copyright

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Lancet. 2013 Nov 9;382(9904):1575-86
pubmed: 23993280
Addiction. 2017 Apr;112(4):705-710
pubmed: 27859902
BMC Public Health. 2018 Aug 15;18(Suppl 1):961
pubmed: 30168393
Psychol Health. 2017 Aug;32(8):976-1017
pubmed: 28513195
Drug Alcohol Rev. 2018 Aug;37 Suppl 2:S53-S62
pubmed: 29900623
Trends Cardiovasc Med. 2017 Nov;27(8):534-538
pubmed: 28735784
PLoS One. 2018 Nov 2;13(11):e0206286
pubmed: 30388130
Eur J Epidemiol. 2017 Jan;32(1):31-42
pubmed: 28097521
Subst Abuse Treat Prev Policy. 2020 Apr 15;15(1):29
pubmed: 32293479
PeerJ. 2017 Jun 30;5:e3507
pubmed: 28674660
Pharmacopsychiatry. 2018 Jul;51(4):136-143
pubmed: 28950395
PLoS One. 2018 Nov 30;13(11):e0208195
pubmed: 30500856
BMC Psychiatry. 2017 May 10;17(1):175
pubmed: 28486959
BMC Public Health. 2019 Nov 6;19(1):1466
pubmed: 31694594
Subst Abuse Treat Prev Policy. 2019 Jun 11;14(1):26
pubmed: 31186050
BMC Public Health. 2017 Jan 11;17(1):64
pubmed: 28077112
Lancet. 2016 Oct 8;388(10053):1603-1658
pubmed: 27733283
Health Promot Int. 2016 Dec;31(4):809-826
pubmed: 26137970
Lancet. 2005 Jan 15-21;365(9455):217-23
pubmed: 15652604
Lancet. 2012 Jul 21;380(9838):219-29
pubmed: 22818936
Drug Alcohol Depend. 2015 Nov 1;156:1-13
pubmed: 26371405
Mayo Clin Proc. 2014 Mar;89(3):382-93
pubmed: 24582196
J Alzheimers Dis. 2016 Mar 29;52(2):529-38
pubmed: 27031466
Addiction. 2016 Sep;111(9):1590-8
pubmed: 27351584
BMC Public Health. 2011 Mar 10;11:160
pubmed: 21392398
Lancet. 2018 Sep 22;392(10152):1072-1088
pubmed: 30264707
Addiction. 2009 Jul;104(7):1147-54
pubmed: 19426287
Addiction. 2017 Feb;112(2):217-218
pubmed: 27649845
Lancet Public Health. 2020 Jan;5(1):e51-e61
pubmed: 31910980
Alcohol Res. 2016;38(1):69-77
pubmed: 27159813
Trop Med Int Health. 2016 Oct;21(10):1209-1239
pubmed: 27429168
Drug Alcohol Rev. 2018 Aug;37 Suppl 2:S63-S71
pubmed: 29707842
Addiction. 2014 Jul;109(7):1081-90
pubmed: 24716508
Bull World Health Organ. 2018 Nov 1;96(11):750-759
pubmed: 30455530
Lancet. 2013 Dec 7;382(9908):1898-955
pubmed: 24309475
Circulation. 2016 Mar 8;133(10):979-87
pubmed: 26936862
BMC Public Health. 2018 Mar 13;18(1):350
pubmed: 29534705
Health Promot Int. 2018 Aug 1;33(4):657-664
pubmed: 28334852
Lancet. 2019 Jun 22;393(10190):2493-2502
pubmed: 31076174
Addiction. 2013 May;108(5):912-22
pubmed: 23347092
Cochrane Database Syst Rev. 2017 Feb 17;2:CD011683
pubmed: 28211056
J Pers Soc Psychol. 1986 May;50(5):899-905
pubmed: 3712230
BMC Public Health. 2018 Nov 7;18(Suppl 3):1216
pubmed: 30400910
Nat Rev Cardiol. 2015 Oct;12(10):576-87
pubmed: 26099843

Auteurs

Bruno Bonnechère (B)

REVAL Rehabilitation Research Center, Faculty of Rehabilitation Sciences, Hasselt University, Diepenbeek, Belgium bruno.bonnechere@uhasselt.be.

Sékou Samadoulougou (S)

Evaluation Platform on Obesity Prevention, Quebec Heart and Lung Institute Research Center, Quebec city, Quebec, Canada.
Centre for Research on Planning and Development (CRAD), Laval University, Quebec city, Quebec, Canada.

Kadari Cisse (K)

Centre de Recherche en Epidémiologie, Biostatistiques et Recherche Clinique, Université Libre de Bruxelles-Ecole de santé publique, Brussels, Belgium.
Institut de Recherche en Sciences de la Sante, Ouagadougou, Burkina Faso.

Souleymane Tassembedo (S)

Département de recherche clinique, Centre Muraz, Bobo-Dioulasso, Burkina Faso.

Seni Kouanda (S)

Institut de Recherche en Sciences de la Sante, Ouagadougou, Burkina Faso.
Institut Africain de Santé publique (IASP), Ouagadougou, Burkina Faso.

Fati Kirakoya-Samadoulougou (F)

Centre de Recherche en Epidémiologie, Biostatistiques et Recherche Clinique, Université Libre de Bruxelles-Ecole de santé publique, Brussels, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH